Angina Treatments in the News
Study says chest pain toll in women is more than physical
LOS ANGELES (August 30, 2006) – Considering both direct and indirect costs, the financial burden on a woman who has chest pain and blocked coronary arteries may
total more than $1 million during her lifetime. But even a woman who suffers from angina without an obstruction can expect her condition to take a toll in the neighborhood of $800,000, according to a
report in the Aug. 29 issue of Circulation.
C. Noel Bairey Merz, M.D., medical director of the Preventive and Rehabilitative Cardiac Center at Cedars-Sinai Medical Center, medical director of Women's Health,
and one of the article's authors, said researchers looked at the cases of 883 women over five years in reaching their conclusions.
"Total cumulative costs were higher for women who have two or three blocked vessels, due largely to the number of outpatient visits and procedures performed. But
women with nonobstructive coronary artery disease (CAD) or one blocked artery had proportionately higher drug costs, which resulted in higher indirect costs," said Bairey Merz, chair of the
Women's Ischemia Syndrome Evaluation (WISE), from which the estimates were derived.
WISE is a multi-center study launched in 1996 that is funded by the National Heart, Lung and Blood Institute of the National Institutes of Health. This research also was
supported by a grant from the National Center for Research Resources.
The research team totaled direct costs from cardiovascular hospitalizations, coronary interventions, outpatient testing, and visits to health care professionals. Indirect
costs included such factors as hours lost from work for health care, estimated reduced productivity hours, transportation charges, and the costs of drugs and medical devices.
For women with obstructive CAD, average lifetime costs were estimated to be more than $1 million. But even for those with nonobstructive CAD the average was $767,288
– and this is a group that has been left out of earlier estimates of the economic burden of heart disease; most studies have focused almost exclusively on men.
"If we had an adequate understanding of the different causes of chest pain in women, we wouldn't be spending all this money on women who have open arteries but
keep cycling through the system. This is not a small problem, and it is not going to go away, which means we must continue to invest in research specific to women," Bairey Merz said.
Among women in the study, those with vessel obstructions tended to be older and postmenopausal with a greater prevalence of cardiac risk factors. Those with
nonobstructive disease were more often obese and with prior hysterectomy, polycystic ovary syndrome and a positive stress test. When the researchers extrapolated lifetime costs from the five-year data,
they took age into consideration. For example, for younger women, total cost was related to greater life expectancy and drug treatment costs.
In a study published earlier this year, the WISE researchers shed light on a female-specific vascular disorder that often causes women to suffer from heart-related chest
pain even though their arteries are not blocked by plaque deposits. Two areas of dysfunction – one in the cells lining coronary arteries and another in the tiny vessels branching within the heart
itself – combine to deprive the heart muscle of oxygen. These functional rather than structural abnormalities, while not seen on coronary angiography, result in abnormal resistance that limits
blood flow to the heart tissue.
"Nearly half of women undergoing clinically indicated coronary angiography have nonobstructive CAD. Now we are beginning to appreciate the financial burden that is
placed upon these women – as well as on the health care system – as they continue to seek medications and therapies to reduce ischemia and angina over their lifetimes," said Bairey Merz,
who holds the Women's Guild Chair in Women's Health at Cedars-Sinai.
Compared with women who have blocked arteries, women with nonobstructive CAD are at lower risk for cardiovascular death, but their ongoing symptoms and therapeutic
interventions affect their general well-being and quality of life. Moreover, according to the study, one woman in five with nonobstructive CAD required hospitalization at some point during the five-year
follow-up period, and 46 percent of those with nonobstructive CAD had typical angina at five years, a rate similar to that of women with blocked arteries.